Skip to content

Baseline Survey on Male Menopausal Symptoms in Japanese Adult Males

Baseline Survey on Male Menopausal Symptoms in Japanese Adult Males - Baseline Survey on Male Menopausal Symptoms in Japanese Adult Males

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000059417
Enrollment
120
Registered
2025-10-15
Start date
2025-10-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy participants

Interventions

None listed

Sponsors

Macromill, Inc.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1.Male participants aged 20 years or older and 69 years or younger at the time of consent. 2.Individuals who have received a thorough explanation of the study's purpose and content and have voluntarily agreed to participate.

Exclusion criteria

Exclusion criteria: 1.Individuals with periodontal disease or oral conditions, or those with a tendency for oral bleeding that may result in blood contamination during saliva collection. 2.Individuals who smoke more than 20 cigarettes per day. 3.Individuals whose daily alcohol consumption exceeds 60 grams. 4.Individuals engaged in shift work or night shifts. 5.Individuals currently participating in other clinical trials or studies, or those who participated within 4 weeks prior to obtaining consent. 6.Individuals unable to comply with the instructions of the principal investigator or deemed unsuitable by the principal investigator.

Design outcomes

Primary

MeasureTime frame
1.Salivary testosterone concentration 2.Salivary cortisol concentration 3.Aging Males' Symptoms (AMS) score

Secondary

MeasureTime frame
1.Basic information (age, height, weight, etc.) 2.Grip strength 3.Dietary survey (Dietary Variety Score: DVS) 4.Lifestyle habits (sleep, exercise, alcohol consumption, smoking habits, daytime posture)

Countries

Japan

Contacts

Public ContactYumi Kimoto

Macromill, Inc. Clinical Trial Department, Life Science Division

kimoto@macromill.com03-6716-0700

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026